World Omni Auto Receivables Trust 2022-C has filed a new report with the Securities and Exchange Commission (SEC), detailing its asset-backed securities. This filing is significant as it provides insights into the trust's performance and the underlying auto loans that support these securities.
The report, filed on October 29, 2026, is part of the ongoing regulatory requirements for asset-backed securities. It includes data on various auto loans originated by World Omni Financial Corp, which serves as the trust's primary loan servicer.
Background
World Omni Auto Receivables Trust 2022-C is categorized under the SIC code 6189, which pertains to asset-backed securities. The trust is involved in the securitization of auto loans, providing investors with access to cash flows generated from these loans. The trust has been active in filing various documents with the SEC, including recent reports on loan performance and asset data.
What the Filing Says
The filing includes an asset data file and an asset-related document that outlines the performance of the underlying loans. Key details from the report indicate that the trust is actively managing a portfolio of auto loans with varying interest rates and terms. For instance, some loans originate from popular Toyota models, indicating a focus on reliable vehicle brands.
Impact
This filing may affect investors and stakeholders in the asset-backed securities market, particularly those interested in auto loans. The data provided can influence investment decisions and market strategies, especially among competitors in the asset-backed securities sector.
What's Next
The filing does not say what happens next, but it is expected that the trust will continue to monitor the performance of its assets and provide updates as required by regulatory standards.
Read Next
Georgia Banking Co Inc files prospectus for share resale
HSBC USA Inc. Offers New Autocallable Income Barrier Notes
HSBC USA Inc. launches Autocallable Contingent Income Notes
BofA Finance files pricing supplement for new income notes
Inmune Bio secures $4.5 million through securities agreement
BofA Finance LLC Files Pricing Supplement for $600,000 Notes









